MedicarePartD.guide

A non-government resource built from CMS public data

Overactive bladder drugs on every 2026 Alaska Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 9 stand-alone Part D plans in Alaska cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Overactive bladder drugs by 2026 Alaska Part D plan
DrugWellcare Classic$0.00/moS4802-096HealthSpring Assurance Rx$0.00/moS5617-227Humana Basic Rx Plan$0.00/moS5884-116Humana Value Rx Plan$10.60/moS5884-213Wellcare Value Script$19.70/moS4802-165AARP Medicare Rx Saver from UHC$53.20/moS5921-377SilverScript Choice$94.90/moS5601-068AARP Medicare Rx Preferred from UHC$100.20/moS5921-415Humana Premier Rx Plan$112.40/moS5884-180
oxybutyningeneric DitropanTier 325%QL 60/30dTier 210%Tier 2$3.00Tier 2$0.00Tier 440%QL 60/30dTier 3PA19%Tier 2$7.00QL 120/30dTier 2PA$10.00Tier 2$4.00
solifenacingeneric VesicareTier 428%QL 30/30dTier 429%Tier 428%QL 30/30dTier 2$0.00QL 30/30dTier 440%QL 30/30dTier 4PA33%QL 30/30dTier 2$7.00QL 30/30dTier 3PA18%QL 30/30dTier 2$4.00QL 30/30d
MyrbetriqmirabegronNot coveredTier 325%Tier 324%QL 30/30dTier 320%QL 30/30dNot coveredNot coveredTier 318%QL 30/30dTier 318%Tier 3$45.00QL 30/30d
mirabegrongeneric MyrbetriqTier 325%QL 30/30dNot coveredNot coveredNot coveredTier 325%QL 30/30dNot coveredNot coveredNot coveredNot covered
GemtesavibegronNot coveredNot coveredNot coveredNot coveredTier 440%QL 30/30dTier 319%Tier 318%QL 30/30dTier 435%Not covered
tolterodinegeneric DetrolTier 428%QL 60/30dTier 429%Tier 428%QL 60/30dTier 433%QL 60/30dTier 440%QL 60/30dNot coveredTier 433%QL 60/30dTier 435%Tier 450%QL 60/30d
trospiumgeneric SancturaTier 325%QL 60/30dNot coveredTier 428%Tier 433%Tier 325%QL 60/30dNot coveredTier 2$7.00QL 60/30dTier 318%Tier 450%

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.